Table 1.
Demographic data of patients with SARS-CoV-2 infection. Data is shown as n (%) or median (IQR).
| Non-cancer | Cancer | p-value | |
|---|---|---|---|
| Total | 226 | 94 | |
| Male | 152 (67%) | 62 (66%) | 0.82 |
| Female | 74 (33%) | 32 (34%) | – |
| Median age (years) | 70.5 (60–80) | 71 (62–80) | 0.42 |
| BMI (kg/m2) | 26.6 (23.5–30.5) | 25.1 (21.7–30.5) | <0.001 |
| Ethnicity | |||
| South Asian | 28 (12%) | 8 (9%) | 0.25 |
| Black | 37 (16%) | 6 (6%) | 0.01 |
| Other | 19 (8%) | 9 (10%) | 0.83 |
| White | 115 (51%) | 64 (68%) | 0.01 |
| Unknown | 27 (12%) | 7 (7%) | – |
| Smoking status | 0.04 | ||
| Lifetime non-smoker | 110 (49%) | 40 (43%) | – |
| Ex-smoker | 58 (26%) | 42 (45%) | – |
| Active smoker | 13 (6%) | 7 (7%) | – |
| Unknown | 17 (8%) | 4 (4%) | – |
| Co-morbidities | |||
| Cardiovascular disease | 59 (26%) | 18 (19%) | 0.18 |
| Dementia | 35 (15%) | 7 (7%) | 0.05 |
| Diabetes | 73 (32%) | 24 (26%) | 0.23 |
| Congestive cardiac failure | 16 (7%) | 9 (10%) | 0.45 |
| Liver disease | 4 (2%) | 3 (3%) | 0.43 |
| Hypertension | 123 (54%) | 37 (39%) | 0.01 |
| Peripheral vascular disease | 13 (6%) | 2 (2%) | 0.16 |
| Cerebrovascular disease | 37 (16%) | 12 (13%) | 0.41 |
| Chronic lung disease | 47 (21%) | 14 (15%) | 0.22 |
| Chronic kidney disease | 26 (12%) | 12 (13%) | 0.75 |
| Ongoing corticosteroid therapy | 13 (6%) | 4 (4%) | 0.59 |
BMI, body mass index.